Trial intelligence / Profile preview

Somatropin vs Eutropin in Adult Growth Hormone Deficiency

NCT02693522Phase 3Completed

Sponsor
Daewoong Pharmaceutical
Start
Oct 2003
Primary completion
Dec 2004
Modality
Hormone, rProtein (Recombinant Protein), Biologic
Countries
1
01

Overview

A Phase 3 trial of somatropin in growth hormone deficiency (GHD), sponsored by Daewoong Pharmaceutical. Started Oct 2003; status: completed.

02

Drugs

somatropin
03

Conditions

growth hormone deficiency (GHD)

Beyond the preview

Go deeper on NCT02693522.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02693522.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call